Olatoyosi Odenike to Quinoxalines
This is a "connection" page, showing publications Olatoyosi Odenike has written about Quinoxalines.
Connection Strength
0.077
-
A phase I and pharmacokinetic study of XK469R (NSC 698215), a quinoxaline phenoxypropionic acid derivative, in patients with refractory acute leukemia. Invest New Drugs. 2008 Aug; 26(4):331-8.
Score: 0.077